# Prevention of Cognitive Decline in Alzheimer's Disease by Ingested Interferon Alpha

> **NCT00031018** · PHASE2 · UNKNOWN · sponsor: **National Center for Research Resources (NCRR)**

## Conditions studied

- Memory Disorders
- Alzheimer's Disease

## Interventions

- **DRUG:** Aricept
- **DRUG:** IFN-alpha2A

## Key facts

- **NCT ID:** NCT00031018
- **Lead sponsor:** National Center for Research Resources (NCRR)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2008-02-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00031018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00031018, "Prevention of Cognitive Decline in Alzheimer's Disease by Ingested Interferon Alpha". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00031018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*